Drug Trial Radar · NCT05980949
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
1,000
Planned (sponsor's estimate)
Start
Jul 11, 2023
Primary completion
Sep 7, 2027
Study completion Sep 7, 2027
Sponsor
- Lead sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb companyBristol Myers Squibb (BMY)
- Sponsor type
- Industry
- First posted
- Aug 8, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 55 years, up to 90 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase 3 global, multicenter, 52-week, open-label extension (OLE) rollover study for subjects completing study CN012-0026, CN012-0027 or CN012-0056. Subjects (randomized or non-randomized) who complete the 38-week CN012-0026 study, 14-week CN012-0027 study or 14-week CN012-0056 study will be eligible to enroll in CN012-0028. The primary objective of the study is to assess the long-term safety and tolerability of KarXT in subjects with psychosis associated with Alzheimer's Disease.
Conditions
- Psychosis Associated With Alzheimer's Disease
Interventions
KarXTDrug
KarXT 20/2 mg TID (total daily dose \[TDD\] 60/6 mg) KarXT 30/3 mg TID (TDD 90/9 mg) KarXT 40/4 mg TID (TDD 120/12 mg) KarXT 50/5 mg TID (TDD 150/15 mg) KarXT 66.7/6.67 mg TID (TDD 200/20 mg)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of treatment-emergent adverse events (TEAEs)Time frame: From initial dose through 14 days after the final dose (up to 54 weeks)
Locations
432 sites in 31 countries. Site status is shown where the registry gives one.
Local Institution - 1029
Homewood, Alabama · Withdrawn
Local Institution - 1-13H98LK9
Chandler, Arizona · Withdrawn
Local Institution - 1227
Chandler, Arizona · Withdrawn
Local Institution - 1116
Chandler, Arizona · Withdrawn
Local Institution - 1247
Gilbert, Arizona · Not yet recruiting
Local Institution - 1217
Phoenix, Arizona · Not yet recruiting
Local Institution - 1044
Phoenix, Arizona · Withdrawn
Local Institution - 1220
Scottsdale, Arizona · Withdrawn
Advanced Research Center, Inc.
Anaheim, California · Recruiting
Local Institution - 1-141NO1DG
Chino, California · Not yet recruiting
Local Institution - 1244
Chino, California · Not yet recruiting
Local Institution - 1001
Costa Mesa, California · Withdrawn
Local Institution - 1151
Encino, California · Withdrawn
Local Institution - 1033
Encino, California · Withdrawn
Local Institution - 1031
Irvine, California · Withdrawn
Local Institution - 1142
Lancaster, California · Withdrawn
Local Institution - 1230
Long Beach, California · Withdrawn
Local Institution - 1117
Los Alamitos, California · Withdrawn
USC - The Memory and Aging Center (MAC) - Alzheimer Disease Research Center (ADRC)
Los Angeles, California · Recruiting
Local Institution - 1228
Orange, California · Not yet recruiting
SC3 Research - Pasadena - 960 E. Green St
Pasadena, California · Recruiting
Local Institution - 1213
Rancho Cucamonga, California · Not yet recruiting
Local Institution - 1103
Sherman Oaks, California · Completed
Sunwise Clinical Research, LLC - Walnut Creek - IVY - PPDS
Walnut Creek, California · Recruiting
Local Institution - 1014
Colorado Springs, Colorado · Withdrawn
University of Connecticut Health Center
Farmington, Connecticut · Recruiting
Local Institution - 1013
Stamford, Connecticut · Withdrawn
Local Institution - 1225
Atlantis, Florida · Withdrawn
Local Institution - 1011
Boca Raton, Florida · Withdrawn
Envision Trials LLC
Bonita Springs, Florida · Recruiting
Local Institution - 1015
Bradenton, Florida · Withdrawn
Local Institution - 1156
Clermont, Florida · Withdrawn
K2 Medical Research - Winter Garden
Clermont, Florida · Recruiting
JY Research Institute Inc
Cutler Bay, Florida · Recruiting
Arrow Clinical Trials
Daytona Beach, Florida · Recruiting
Local Institution - 1224
Deerfield Beach, Florida · Withdrawn
Local Institution - 1162
Delray Beach, Florida · Withdrawn
Integrity Clinical Research LLC - 21st Street
Doral, Florida · Recruiting
Betancourt Research Services
Doral, Florida · Recruiting
Local Institution - 1165
Fort Myers, Florida · Withdrawn
Showing 40 of 432 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.